Sarepta Therapeutics Inc (SRPT)
112.44
-1.85
(-1.62%)
USD |
NASDAQ |
Nov 13, 16:00
112.60
+0.16
(+0.14%)
After-Hours: 20:00
Sarepta Therapeutics Total Return Level: 114.29 for Nov. 12, 2024
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 12, 2024 | 114.29 |
| November 11, 2024 | 117.84 |
| November 08, 2024 | 121.61 |
| November 07, 2024 | 120.42 |
| November 06, 2024 | 127.97 |
| November 05, 2024 | 125.01 |
| November 04, 2024 | 123.07 |
| November 01, 2024 | 123.29 |
| October 31, 2024 | 126.00 |
| October 30, 2024 | 127.78 |
| October 29, 2024 | 130.21 |
| October 28, 2024 | 130.26 |
| October 25, 2024 | 131.14 |
| October 24, 2024 | 132.02 |
| October 23, 2024 | 129.88 |
| October 22, 2024 | 128.42 |
| October 21, 2024 | 127.31 |
| October 18, 2024 | 127.08 |
| October 17, 2024 | 124.25 |
| October 16, 2024 | 125.92 |
| October 15, 2024 | 123.73 |
| October 14, 2024 | 124.37 |
| October 11, 2024 | 124.51 |
| October 10, 2024 | 122.41 |
| October 09, 2024 | 117.99 |
| Date | Value |
|---|---|
| October 08, 2024 | 119.72 |
| October 07, 2024 | 117.79 |
| October 04, 2024 | 120.40 |
| October 03, 2024 | 118.76 |
| October 02, 2024 | 122.52 |
| October 01, 2024 | 122.33 |
| September 30, 2024 | 124.89 |
| September 27, 2024 | 124.53 |
| September 26, 2024 | 124.84 |
| September 25, 2024 | 124.62 |
| September 24, 2024 | 125.49 |
| September 23, 2024 | 124.79 |
| September 20, 2024 | 127.21 |
| September 19, 2024 | 127.10 |
| September 18, 2024 | 125.01 |
| September 17, 2024 | 125.69 |
| September 16, 2024 | 124.33 |
| September 13, 2024 | 124.65 |
| September 12, 2024 | 125.34 |
| September 11, 2024 | 128.39 |
| September 10, 2024 | 126.94 |
| September 09, 2024 | 127.69 |
| September 06, 2024 | 128.92 |
| September 05, 2024 | 133.77 |
| September 04, 2024 | 134.79 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
111.27
Average
114.82
Median
Oct 06 2022
Total Return Level Benchmarks
| Catalyst Pharmaceuticals Inc | 23.04 |
| Vertex Pharmaceuticals Inc | 490.00 |
| Alnylam Pharmaceuticals Inc | 268.95 |
| Biomarin Pharmaceutical Inc | 66.12 |
| Cytokinetics Inc | 56.20 |